Home
News & Events
RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME
RECORDATI RARE DISEASES TO PRESENT NEW DATA IN CUSHING’S DISEASE AND CUSHING’S SYNDROME AT ENDO 2024
RECORDATI RARE DISEASES ANNOUNCES THE CALL FOR APPLICATIONS TO THE ELEVENTH EDITION OF THE INTERNATIONAL PRIZE FOR SCIENTIFIC RESEARCH ARRIGO RECORDATI
Our Products
Recordati Rare Diseases has a robust portfolio of therapies that target a wide range of medical conditions, and are designed to meet the needs of underserved patient populations.
Cystadrops
- U.S. Prescribing Information
- www.cystadrops.com
- To order CYSTADROPS in the U.S.
Contact Anovo: Tel: 1-866-925-6212
Isturisa
- U.S. Prescribing Information
- www.isturisa.com
- To order ISTURISA in the U.S.
Contact Anovo: Tel: 1-888-855-RARE (7273)
About Us
Recordati Rare Diseases develops high-impact therapies for devastating rare diseases. At Recordati, we focus on the few - those affected by rare diseases. They are our top priority and at the core of everything we do.
